Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1

被引:162
|
作者
Otero, M
Lago, R
Lago, F
Reino, JJG
Gualillo, O [1 ]
机构
[1] Santiago Univ Clin Hosp, NEIRID Lab, Res Lab 4, Santiago De Compostela, Spain
[2] Santiago Univ Clin Hosp, Lab Mol & Cellular Cardiol, Res Lab 1, Santiago De Compostela, Spain
[3] Santiago Univ Clin Hosp, Div Rheumatol, Santiago De Compostela, Spain
[4] Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain
关键词
D O I
10.1186/ar1708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present study was to investigate the effect of leptin, alone or in combination with IL-1, on nitric oxide synthase ( NOS) type II activity in vitro in human primary chondrocytes, in the mouse chondrogenic ATDC5 cell line, and in mature and hypertrophic ATDC5 differentiated chondrocytes. For completeness, we also investigated the signalling pathway of the putative synergism between leptin and IL-1. For this purpose, nitric oxide production was evaluated using the Griess colorimetric reaction in culture medium of cells stimulated over 48 hours with leptin (800 nmol/l) and IL-1 (0.025 ng/ml), alone or combined. Specific pharmacological inhibitors of NOS type II (aminoguanidine [1 mmol/l]), janus kinase (JAK) 2 (tyrphostin AG490 and Tkip), phosphatidylinositol 3-kinase (PI3K; wortmannin [1, 2.5, 5 and 10 mu mol/l] and LY294002 [1, 2.5, 5 and 10 mu mol/l]), mitogen-activated protein kinase kinase (MEK) 1 (PD098059 [1, 5, 10, 20 and 30 mu mol/l]) and p38 kinase (SB203580 [1, 5, 10, 20 and 30 mu mol/l]) were added 1 hour before stimulation. Nitric oxide synthase type II mRNA expression in ATDC5 chondrocytes was investigated by real-time PCR and NOS II protein expression was analyzed by western blot. Our results indicate that stimulation of chondrocytes with IL-1 results in dose-dependent nitric oxide production. In contrast, leptin alone was unable to induce nitric oxide production or expression of NOS type II mRNA or its protein. However, co-stimulation with leptin and IL-1 resulted in a net increase in nitric oxide concentration over IL-1 challenge that was eliminated by pretreatment with the NOS II specific inhibitor aminoguanidine. Pretreatment with tyrphostin AG490 and Tkip (a SOCS-1 mimetic peptide that inhibits JAK2) blocked nitric oxide production induced by leptin/IL-1. Finally, wortmannin, LY294002, PD098059 and SB203580 significantly decreased nitric oxide production. These findings were confirmed in mature and hypertrophic ATDC5 chondrocytes, and in human primary chondrocytes. This study indicates that leptin plays a proinflammatory role, in synergy with IL-1, by inducing NOS type II through a signalling pathway that involves JAK2, PI3K, MEK-1 and p38 kinase.
引用
收藏
页码:R581 / R591
页数:11
相关论文
共 50 条
  • [41] High glucose potentiates nitric oxide synthase II induction by interleukin-1β in cultured human aortic smooth muscle.
    Lafuente, N
    Matesanz, N
    Azcutia, V
    El-Assar, M
    Cercas, E
    Vallejo, S
    Nevado, J
    Rodriguez-Mañas, L
    Peiro, C
    Sanchez-Ferrer, CF
    DIABETOLOGIA, 2003, 46 : A387 - A387
  • [42] Downregulation of neuronal nitric oxide synthase and interleukin-1β mediates angiotensin II-dependent stimulation of sympathetic nerve activity
    Campese, VM
    Ye, SH
    Zhong, HQ
    HYPERTENSION, 2002, 39 (02) : 519 - 524
  • [43] Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis
    Zhao, ML
    Kim, MO
    Morgello, S
    Lee, SC
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 115 (1-2) : 182 - 191
  • [44] Effect of interleukin-1 receptor type II in the pathogenesis of endometriosis
    Hou, Z.
    Zhou, J.
    Liu, J.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2006, 71 (02) : 162 - 162
  • [45] Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes
    Stradner, M. H.
    Hermann, J.
    Angerer, H.
    Setznagl, D.
    Sunk, I. -G.
    Windhager, R.
    Graninger, W. B.
    OSTEOARTHRITIS AND CARTILAGE, 2008, 16 (03) : 305 - 311
  • [46] Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts
    Okada, Muneyoshi
    Yamawaki, Hideyuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 86 - 92
  • [47] Synergistic effect of angiotensin II type 1 receptor and endothelial nitric oxide synthase mutations on increased stiffness of peripheral arteries in general population
    Mayer, Otto
    Filipovsky, Jan
    Pesta, Martin
    JOURNAL OF HYPERTENSION, 2006, 24 : 322 - 322
  • [48] Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes
    Chen, Wei-Ping
    Wang, Yu-Lu
    Tang, Jing-Li
    Hu, Peng-Fei
    Bao, Jia-Peng
    Wu, Li-Dong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 12 (02) : 447 - 452
  • [49] THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1
    COLOTTA, F
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    IMMUNOLOGY TODAY, 1994, 15 (12): : 562 - 566
  • [50] N-acetyl-L-cysteine enhances interleukin-1β-induced nitric oxide synthase expression
    Jiang, BB
    Haverty, M
    Brecher, P
    HYPERTENSION, 1999, 34 (04) : 574 - 579